Lee Hambright

Q: What is Lee Hambright's success rate?

Lee Hambright currently has a success rate of 73.08924672086306.

Q: What is the average return of Lee Hambright's calls?

Their stock ratings have generated an average return of 13.143987982567294.

Bernstein | Healthcare

Lee Hambright is an analyst from Bernstein specializing in the Healthcare sector. Ranked #2382 out of 4771 analysts, they have issued 18 stock ratings with a success rate of 73.09% and an average return of 13.14%.

With 18 ratings to date, Lee Hambright is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 73.09% and an average return of 13.14%, highlighting promising potential as their track record develops further.

#2382

Out of 4771

Total Ratings

+73.09%

Success Rate

+13.14%

Average Return

Recent Ratings Analysis

ISRG

Buy

Jul 17, 2026

Target

$685.00

Current

$360.46

Performance

4.35%

Lee Hambright rated ISRG as Outperform on Jul 17, 2026, setting a price target of 685. Shares have remained stable near 360.46, leaving the 685 target still in play.

MDT

Buy

Jun 05, 2026

Target

$97.00

Current

$91.62

Performance

12.18%

On Jun 05, 2026, MDT was given a Outperform rating by Lee Hambright, with a target price of 97. The stock rallied 12.18% after the rating, narrowing the gap to the target of 97 and validating the bullish stance.

MDLN

Buy

May 07, 2026

Target

$54.00

Current

$32.39

Performance

-22.62%

MDLN received a Outperform rating from Lee Hambright on May 07, 2026, aiming for 54. The rating hasn’t played out as hoped, with the stock trading 22.62% below expectations.

PODD

Buy

May 07, 2026

Target

$200.00

Current

$134.68

Performance

-16.03%

On May 07, 2026, Lee Hambright published a Outperform outlook on PODD, with a target of 200. Market action contradicted the Buy thesis, as shares slipped to 134.68.

ABT

Buy

Jan 23, 2026

Target

$125.00

Current

$103.37

Performance

-3.77%

Lee Hambright on Jan 23, 2026 assigned ABT a Outperform rating, with a price target of 125. The recommendation remains pending validation as shares consolidate around 103.37.

ZBH

Hold

Jan 09, 2026

Target

$99.00

Current

$92.44

Performance

-0.44%

On Jan 09, 2026, Lee Hambright reaffirmed ZBH with a Market Perform rating, targeting 99. The neutral call matched muted market action of -0.44%.

DXCM

Buy

Jan 09, 2026

Target

$86.00

Current

$84.51

Performance

25.39%

DXCM was rated Outperform by Lee Hambright on Jan 09, 2026, with a price objective of 86. A bullish response from the market helped close the gap of 1.49 to the target.

JNJ

Hold

Jan 09, 2026

Target

$208.00

Current

$266.35

Performance

30.31%

On Jan 09, 2026, Lee Hambright initiated coverage on JNJ with a Market Perform rating and target of 208. The Hold stance underestimated the stock’s strength as it gained 30.31%.

SYK

Buy

Jan 09, 2026

Target

$465.00

Current

$270.01

Performance

-26.54%

Lee Hambright issued a Outperform recommendation for SYK on Jan 09, 2026, price target set at 465. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

TNDM

Hold

Jan 09, 2026

Target

$25.00

Current

$18.31

Performance

-15.62%

On Jan 09, 2026, TNDM was evaluated by Lee Hambright, who gave a Market Perform rating and target of 25. The Hold call avoided chasing into subsequent weakness of 15.62%.

BSX

Buy

Oct 24, 2024

Target

$100.00

Current

$43.10

Performance

-49.35%

Lee Hambright rated BSX as Outperform on Oct 24, 2024, setting a price target of 100. The stock has underperformed, dropping 49.35% despite the bullish target of 100.

Frequency Asked Questions

Who is Lee Hambright?

Lee Hambright is an analyst from Bernstein specializing in the Healthcare sector.

What is Lee Hambright's success rate?

Lee Hambright currently has a success rate of +73.09%.

How many ratings has Lee Hambright issued?

Lee Hambright has issued 18 stock ratings so far.

What is the average return of Lee Hambright's calls?

Their stock ratings have generated an average return of +13.14%.

What is Lee Hambright's ranking?

Lee Hambright is ranked #2382 out of 4771 analysts.

What types of ratings does Lee Hambright give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Lee Hambright?

You can follow Lee Hambright by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Lee Hambright?

Their latest rating was a Buy on ISRG issued on 2026-07-17.